Skip to content

{ Tag Archives } Collaboration

Discovery Leads To Effective Treatment Of Painful Skin Condition

Researchers at Huntsman Cancer Institute, in collaboration with a worldwide group of physicians and scientists, have discovered a remarkable treatment for a rare, yet debilitating, skin condition. The study, published online November 24 in Molecular Therapy describes a new treatment for pachyonychia congenita, an ultra-rare genetic skin condition caused by mutations in [...]

Bookmark and Share Also tagged , , , , , , , , , ,

Treatment Of Severe Burn Injuries

Almost three quarters of patients with extensive burns die of the consequences of a severe infection. In the current edition of Deutsches Arzteblatt International, Timo A. Spanholtz of the Cologne-Merheim Burn Center and his coauthors discuss the acute therapy and follow-up care of burn disease. Optimal treatment of severely burned patients necessitates [...]

Bookmark and Share Also tagged , , , , , , , , , , , ,

National Jewish Health And Ceragenix Announce Compound Shows Promise For Treating Potentially Lethal Viral Infections

Ceragenix Pharmaceuticals, Inc.(”Ceragenix”) (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, announced that researchers at National Jewish Health, led by Dr. Donald Y. Leung and Dr. Michael Howell, in collaboration with Dr. Paul B.

Bookmark and Share Also tagged , , , , , , , , , , , , ,

New Risk Variant For Atopic Dermatitis Identified

Scientists of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch and Charité – University Medical School, Berlin, Germany, in collaboration with researchers from the Klinikum rechts der Isar of Technical University Munich and Christian Albrecht University, Kiel, have identified a gene variant on chromosome 11 that is associated with an increased risk of atopic [...]

Bookmark and Share Also tagged , , , , , , , , , , , , , ,